Inventor · disambiguated record
Christopher Frampton
Also filed as: FRAMPTON CHRISTOPHER · FRAMPTON CHRISTOPHER S · FRAMPTON CHRISTOPHER STEPHEN
14 granted patents·6 pending applications·36 citations·filing 2005–2025
87Inventor score
Files withNUFORMIX LTD4NUFORMIX TECH LIMITED3CONDUIT UK MAN LTD2DYNOGEN PHARMACEUTICALS INC2HOLLAND JOANNE2
Top patents by PatentIndex Score
20 records- 0189US7269245B2Combinatorial screening system and X-ray diffraction and Raman spectroscopyBRUKER AXS INC·Filed 2005·Granted Sep 11, 2007·27 cites·20 claims
- 0279US9512064B2Tranilast compositions and cocrystalsNUFORMIX LTD·Filed 2013·Granted Dec 6, 2016·4 cites·8 claims
- 0378US11078155B2Crystalline tranilast salts and their pharmaceutical useNUFORMIX TECH LIMITED·Filed 2019·Granted Aug 3, 2021·2 cites·21 claims
- 0472US9822066B2Tranilast compositions and cocrystalsNUFORMIX LTD·Filed 2016·Granted Nov 21, 2017·1 cites·8 claims
- 0571US12378227B2Therapeutic cocrystals of 3-{[5-(azetidine-1-ylcarbonyl)pyrazin-2-yl]oxy}-5-{[(1S)-1-methyl-2-(methyloxy)ethyl]oxy)-N-(5-methylpyrazin-2-yl)benzamideCONDUIT UK MAN LTD·Filed 2022·Granted Aug 5, 2025·0 cites·14 claims
- 0669US9029369B2Aprepitant L-proline composition and cocrystalHOLLAND JOANNE·Filed 2011·Granted May 12, 2015·2 cites·12 claims
- 0763US12084399B2Crystalline tranilast salts and their pharmaceutical useNUFORMIX TECH LIMITED·Filed 2021·Granted Sep 10, 2024·0 cites·22 claims
- 0861US2025282763A1Therapeutic cocrystals of 3-{[5-(azetidine-1-ylcarbonyl)pyrazin-2-yl]oxy}-5-{[(1s)-1-methyl-2-(methyloxy)ethyl]oxy)-n-(5-methylpyrazin-2-yl)benzamideCONDUIT UK MAN LTD·Filed 2025·Application pending·0 cites
- 0960US12012386B2Olaparib oxalic acid cocrystals and their pharmaceutical useNUFORMIX TECH LIMITED·Filed 2021·Granted Jun 18, 2024·0 cites·12 claims
- 1060US7998994B2Solid forms of (1R,2S,3R)-1-(2-(isoxazol-3-yl)-1H-imidazol-4-yl)butane-1,2,3,4-tetraol and methods of their useLEXICON PHARMACEUTICALS INC·Filed 2009·Granted Aug 16, 2011·0 cites·8 claims
- 1154US2023183202A1Tetrahydrococannabinolic acid cocrystalsEBERS TECH INC·Filed 2021·Application pending·0 cites
- 1253US10150729B2Tranilast compositions and cocrystalsNUFORMIX LTD·Filed 2017·Granted Dec 11, 2018·0 cites·13 claims
- 1350US8592472B2Co-crystalsFORREST JAMES OWEN·Filed 2009·Granted Nov 26, 2013·0 cites·19 claims
- 1448US2007254899A1Soluble salts of thieno[2,3-d]pyrimidine derivativesDYNOGEN PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 1547US9532993B2Aprepitant L-proline solvates—compositions and cocrystalsNUFORMIX LTD·Filed 2012·Granted Jan 3, 2017·0 cites·20 claims
- 1647US8871793B2Metaxalone cocrystalsHOLLAND JOANNE·Filed 2010·Granted Oct 28, 2014·0 cites·24 claims
- 1744US8779146B2Cilostazol cocrystals and compositionsCHORLTON ALAN·Filed 2011·Granted Jul 15, 2014·0 cites·12 claims
- 1844US2007254891A1Crystalline forms of 4-(2-fluorophenyl)-6-methyl-2-(piperazin-1-yl)thieno[2,3-d]pyrimidineDYNOGEN PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 1942US2012202825A1Soluble Salts of Thieno [2,3-d] Pyrimidine DerivativesCOOPER MARTIN IAN·Filed 2011·Application pending·0 cites
- 2032US2011086891A1Solid Forms of 2-(2,4-Difluorophenyl)-6-(1-(2,6-Difluorophenyl)Ureido)Nicotinamide)VERTEX PHARMA·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christopher Frampton files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →